1378 related articles for article (PubMed ID: 15002818)
1. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
Gisbert JP; Legido J; García-Sanz I; Pajares JM
Dig Liver Dis; 2004 Feb; 36(2):116-20. PubMed ID: 15002818
[TBL] [Abstract][Full Text] [Related]
2. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.
Labenz J; Peitz U; Köhl H; Kaiser J; Malfertheiner P; Hackelsberger A; Börsch G
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):110-5. PubMed ID: 10363194
[TBL] [Abstract][Full Text] [Related]
5. Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection.
Pérez-Aisa MA; Del Pino D; Siles M; Lanas A
Aliment Pharmacol Ther; 2005 Jan; 21(1):65-72. PubMed ID: 15644047
[TBL] [Abstract][Full Text] [Related]
6. Effect of non-steroidal anti-inflammatory drugs on gastric and duodenal prostaglandin concentrations in patients with Helicobacter pylori infection.
Tseng GY; Lin HJ; Lin HY; Perng CL; Lee FY; Lo WC; Tsay SH; Li AS; Chang FY; Lee SD
Hepatogastroenterology; 1999; 46(26):1000-4. PubMed ID: 10370655
[TBL] [Abstract][Full Text] [Related]
7. Effect of Helicobacter pylori eradication on the ulcer recurrence rate after simple closure of perforated duodenal ulcer: retrospective and prospective randomized controlled studies.
Kate V; Ananthakrishnan N; Badrinath S
Br J Surg; 2001 Aug; 88(8):1054-8. PubMed ID: 11488789
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
Vergara M; Catalán M; Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan.
Chen TS; Luo JC; Chang FY
J Gastroenterol Hepatol; 2010 May; 25(5):919-22. PubMed ID: 20074147
[TBL] [Abstract][Full Text] [Related]
10. [Helicobacter pylori, gastric ulcer and non-steroidal anti-inflammatory agents].
Boixeda D; Gisbert JP; Cantón R; Alvarez Baleriola I; Bermejo F; Aller R; Martín de Argila C
Med Clin (Barc); 1996 Feb; 106(6):209-12. PubMed ID: 8667661
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
[TBL] [Abstract][Full Text] [Related]
12. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori and nonsteroidal anti-inflammatory drugs in perforations and bleeding of peptic ulcers.
Bobrzyński A; Konturek PC; Konturek SJ; Płonka M; Bielański W; Karcz D
Med Sci Monit; 2005 Mar; 11(3):CR132-5. PubMed ID: 15735566
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection in patients with perforated duodenal ulcer.
Chowdhary SK; Bhasin DK; Panigrahi D; Malik AK; Kataria RN; Behra A; Roy P; Singh K
Trop Gastroenterol; 1998; 19(1):19-21. PubMed ID: 9641028
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
Gisbert JP; Gonzalez L; de Pedro A; Valbuena M; Prieto B; Llorca I; Briz R; Khorrami S; Garcia-Gravalos R; Pajares JM
Scand J Gastroenterol; 2001 Jul; 36(7):717-24. PubMed ID: 11444470
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Helicobacter pylori infection among patients with dyspepsia in South-Western Saudi Arabia.
Ayoola AE; Ageely HM; Gadour MO; Pathak VP
Saudi Med J; 2004 Oct; 25(10):1433-8. PubMed ID: 15494817
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of bleeding peptic ulcers: a prospective study.
Liu NJ; Lee CS; Tang JH; Cheng HT; Chu YY; Sung KF; Lin CH; Tsou YK; Lien JM; Chen PC; Chiu CT; Cheng CL
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e340-7. PubMed ID: 17944885
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of Helicobacter pylori infection in duodenal ulcer. Data of a prospective study apropos of 78 NSAID-negative patients with duodenal ulcer].
Ben Ammar A; Cheikh I; Ouerghi H; Chaabouni H; Kchaou M; Ben Mami N
Tunis Med; 2002 Oct; 80(10):599-604. PubMed ID: 12632753
[TBL] [Abstract][Full Text] [Related]
19. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
[TBL] [Abstract][Full Text] [Related]
20. Surgical management of perforated duodenal ulcer: the changing scene.
Plummer JM; McFarlane ME; Newnham
West Indian Med J; 2004 Dec; 53(6):378-81. PubMed ID: 15816264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]